We hope that our work describing the molecular relationship of DYRK3 within mitochondrial dynamics, and metabolic reprogramming will help clarify how DYRK3 alters GBM radioresistance and guide novel DYRK3-informed treatments for GBM patients. This evidence concerns the gene DYRK3 and glioblastoma.